The former includes cases with BCR::ABL1 and KMT2A rearrangements (both also previously recognized by WHO-HAEM4R) and two new entities: MPAL with ZNF384 rearrangement and ALAL/MPAL with BCL11 rearrangement/activation. Here, KMT2A is linked to mixed phenotype acute leukemia.